Troutman Pepper Advises MVM Partners in Neurolens Investment

PHILADELPHIA – Neurolens, a company commercializing innovative solutions to optimize vision, recently completed a $67 million financing led by Troutman Pepper client MVM Partners, a life sciences investment fund focused on innovative health care companies in medical technology, pharmaceuticals, diagnostics, and digital health. Additional participants included Falcon Vision/KKR, Marshall Wace, and existing investors including Bluestem Capital. Read a company press release about the financing.

With patented Contoured Prism technology, Neurolens prescription lenses go beyond visual acuity to provide comfort for adults suffering headaches, neck/shoulder pain, and eyestrain when using digital devices, reading, or doing detail work.

The Troutman Pepper team advising MVM in the investment included Chris Miller, Dan Sieck, Celia Marcum, Joseph Goldman, Daniel Anziska, and Ethan Zook, among others.

Troutman Pepper is a go-to firm for life sciences transactions with a large, multidisciplinary team with deep understanding of the space. The firm regularly advises pharmaceutical, biotech, medical device, diagnostics, and other life sciences clients on all types of corporate matters — governance and general corporate advice; M&A transactions; licensing transactions and other complex collaborations; IPOs, follow-on public offerings, PIPE transactions, and other capital markets transactions; seed and later-stage venture capital financings; and much more.

About Troutman Pepper
Troutman Pepper is a national law firm with more than 1,200 attorneys strategically located in 23 U.S. cities. The firm’s litigation, transactional, and regulatory practices advise a diverse client base, from startups to multinational enterprises. The firm provides sophisticated legal solutions to clients’ most pressing business challenges, with depth across industry sectors, including energy, financial services, health sciences, insurance, and private equity, among others. Learn more at troutman.com.